Global Vaccines (United States)

Recent papers from Global Vaccines (United States)

1. GMMA as adjuvant and carrier for mucosal delivery of group A streptococcus glycoconjugate vaccineHuman Vaccines & Immunotherapeutics · 2026
2. Lyme Borreliosis Awareness, Risk Perception, and Willingness to Vaccinate in France: Where Do We Stand?Pathogens · 2026
3. Seroprevalence of anti-Borrelia IgG antibodies in blood donors in SwedenTicks and Tick-borne Diseases · 2026
4. Clinical and economic impact of bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccination in older adults: a cost-effectiveness analysis for ChileExpert Review of Vaccines · 2026
5. Crosstalk between Mycobacterium tuberculosis and SARS-CoV-2 defines divergent cellular composition of murine responsesFrontiers in Immunology · 2026
6. Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccineThe Journal of Infectious Diseases · 2026
7. Viral Circulation Patterns and Hospitalisation Burden of SARS-CoV-2 and Influenza in the Post-Pandemic Period: An Analysis of Surveillance Data from the United States, England and Europe, 2022-2025Research Connections · 2026
8. Community-Level Patterns in Lyme Disease Incidence Among Medicare and Medicaid BeneficiariesInternational Journal of Environmental Research and Public Health · 2026
9. Whooping cough hospitalisations among patients with chronic conditions: a retrospective analysis of incidence and costs, France, 2008 to 2020Eurosurveillance · 2026
10. Characterization of vaccine viremia, attenuation reversion, and safety: Combined results from the TAK-003 dengue vaccine clinical development programVaccine · 2026
11. Cost-effective production of vi polysaccharide through high-cell-density fermentation using animal component-free media for typhoid vaccinesPreparative Biochemistry & Biotechnology · 2026
12. Asthma-related Pediatric Healthcare Utilization after Hospitalization for RSV and Other Viral Lower Respiratory Tract InfectionsOpen Forum Infectious Diseases · 2026
13. Development of a GMMA-based candidate vaccine against invasive nontyphoidal Salmonella diseaseFrontiers in Immunology · 2026
14. Immune response to rotavirus vaccines in low- and middle-income countries: Challenges and perspectivesHuman Vaccines & Immunotherapeutics · 2026
15. Immunogenicity of a Bivalent Typhoid–Paratyphoid Conjugate Vaccine Against Diverse Salmonella Paratyphi A IsolatesThe Journal of Infectious Diseases · 2026
16. Hospitalisation Burden Estimates of Respiratory Syncytial Virus with Adjustment for Case Underascertainment in Adults Aged 18 to 65 Years in High-income Countries: a Systematic Review, Meta-analysis, and Modelling StudyOpen Forum Infectious Diseases · 2026
17. Exploring the Lived Experience of Acne in the United States and the United Kingdom: Social Media AnalysisJMIR Dermatology · 2026
18. Estimated pneumococcal disease burden in children due to serotypes covered by different pneumococcal conjugate vaccines in five Latin American countriesFrontiers in Pediatrics · 2026
19. Detection of suitable habitat areas in Japan of the Lyme disease and tick-borne encephalitis vectors Ixodes ovatus and Ixodes persulcatus based on abiotic factorsCurrent Research in Parasitology and Vector-Borne Diseases · 2026
20. Development and characterization of pseudotype-based microneutralization assay to assess functionality of anti-rabies protein G antibodiesF1000Research · 2026